Other PBC candidates coming through the collective industry pipeline include CymaBay's seladelpar and Zydus Cadila's saroglitazar - both PPAR agonists – as well as Genkyotex' NOX 1 and 4 ...
Several copycat versions of the drug have already been approved, including from Zydus Cadila and Lupin Labs. However, given Astellas’ plan to elevate the case to the Court of Appeals for the ...
The National Pharmaceutical Pricing Authority (NPPA) has fixed prices of 80 new drugs including anti-diabetes, anti-hypertension, pain relief formulations from major pharmaceutical companies, in its ...
Zydus Lifesciences Limited (Formerly known as Cadila Healthcare Limited) is one of the leading innovation driven pharmaceutical companies in India with presence across the pharmaceutical value ...
Zydus Lifesciences Ltd share price was down by -1.77% from the previous closing price of ₹923.70. Who are peers of Zydus Lifesciences Ltd? The peers of Zydus Lifesciences Ltd are Sun ...
Branded Generics _Market Global Branded Generics Market Include– Sun Pharmaceutical Industries Ltd., Cipla Ltd., Dr. Reddy's Laboratories L ...
The Global Smoking Cessation and Nicotine De-Addiction Products Market is valued at approximately USD 24.54 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 10.77% ...
The global telmisartan market was valued at $3,453 million in 2019, and is projected to reach $4,258 million by 2027, registering a CAGR of 3.4% from 2020 to 2027. The growth of the global telmisartan ...
The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
Nippon India Small Cap Fund (B) 467.76 29,95,942 0.92 Nippon India Small Cap Fund (IDCW) 467.76 29,95,942 0.92 Nippon India Small Cap Fund (G) 467.76 29,95,942 0.92 ...
Zydus Wellness Ltd., incorporated in the year 1994, is a Mid Cap company (having a market cap of Rs 10,296.00 Crore) operating in FMCG sector. Zydus Wellness Ltd. key Products/Revenue Segments include ...
Revenue 19,547.40 17,237.40 15,109.90 14,403.50 ...